Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M86.8Revenue (TTM) $M18.7Net Margin (%)0.5Altman Z-Score-5.9
Enterprise Value $M30.8EPS (TTM) $-0.0Operating Margin %-3.2Piotroski F-Score3
P/E(ttm)--Beneish M-Score-0.6Pre-tax Margin (%)0.5Higher ROA y-yY
Price/Book1.210-y EBITDA Growth Rate %--Quick Ratio7.6Cash flow > EarningsN
Price/Sales9.05-y EBITDA Growth Rate %-17.1Current Ratio7.6Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)0.1Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-1.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M50.4ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with INFI

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

INFI is held by these investors:



INFI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
VENUTI MICHAEL CDirector 2017-03-17Sell6,250$3.48-50.57view
BIOTECHNOLOGY VALUE FUND L P10% Owner 2017-01-03Buy4,379$1.3428.36view
BIOTECHNOLOGY VALUE FUND L P10% Owner 2016-12-30Buy742,401$1.3428.36view
BIOTECHNOLOGY VALUE FUND L P10% Owner 2016-12-20Buy654,921$1.3131.3view
KANGO SUJAYChief Commercial Officer 2016-12-13Sell75,000$1.2834.38view
BIOTECHNOLOGY VALUE FUND L P10% Owner 2016-12-02Buy201,394$1.1944.54view
Perkins Adelene QPresident & CEO 2015-06-25Sell5,000$10.93-84.26view
Palombella Vito J.Chief Scientific Officer 2015-06-15Sell4,737$10.97-84.32view
Perkins Adelene QPresident & CEO 2015-05-27Sell10,000$12.81-86.57view
Perkins Adelene QPresident & CEO 2015-05-14Sell10,000$12.18-85.88view

Quarterly/Annual Reports about INFI:

News about INFI:

Articles On GuruFocus.com
Infinity Provides Company Update and Reports First Quarter 2017 Financial Results May 09 2017 
Infinity Announces the Date of Its First Quarter 2017 Financial Results Conference Call and Webcast Apr 26 2017 
Updated Phase 1 Data for IPI-549 Presented at AACR Annual Meeting 2017 Apr 01 2017 
Pernix: An Investor's Rationale to Staying Long Mar 23 2017 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 04 2010 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) May 06 2010 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 06 2009 

More From Other Websites
Edited Transcript of INFI earnings conference call or presentation 9-May-17 8:30pm GMT May 15 2017
Infinity reports 1Q loss May 09 2017
Infinity Provides Company Update and Reports First Quarter 2017 Financial Results May 09 2017
Endo (ENDP) Beats on Q1 Earnings, Reaffirms '17 Guidance May 09 2017
Horizon (HZNP) Falls on Q1 Earnings Miss, Guidance Trimmed May 09 2017
Investor Network: Infinity Pharmaceuticals, Inc. to Host Earnings Call May 09 2017
Catalent (CTLT) Shows Strength: Stock Adds 9.8% in Session May 08 2017
Agenus (AGEN) Reports Narrower-than-Expected Loss in Q1 May 05 2017
Alkermes (ALKS) Q1 Loss Wider than Expected, Sales Miss Apr 28 2017
Infinity Announces the Date of Its First Quarter 2017 Financial Results Conference Call and Webcast Apr 26 2017
ETFs with exposure to Infinity Pharmaceuticals, Inc. : April 19, 2017 Apr 19 2017
Ultragenyx's Hypophosphatemia Drug Succeeds in Phase III Apr 19 2017
Why Is Infinity (INFI) Down 37.4% Since the Last Earnings Report? Apr 19 2017
Infinity Pharmaceuticals (INFI) Looks Good: Stock Jumps 19% Apr 18 2017
Today's Research Reports on Biotech Stocks to Watch: Cleveland BioLabs and Infinity Pharmaceuticals Apr 18 2017
Bio-Path Holdings (BPTH) Looks Good: Stock Moves 13% Higher Apr 17 2017
Infinity Pharmaceuticals Focuses on Lead Candidate IPI-549 Apr 10 2017
New Strong Buy Stocks for April 10th Apr 10 2017
Cardiome Pharma (CRME) Jumps: Stock Adds 6.6% in Session Apr 10 2017
Ismailia National Food Industries : Neutral assessment on price but strong on fundamentals Apr 06 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)